Suma Ramadas, PhDMedical Affairs
Matthew DurhamOmnidynamic Marketing
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
Joey CohenMedication Adherence
Matt TurnerPatient Affordability
Bud BilanichSuccess Coach
Stacey GandlerBrand Nourishment
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
Paul TheisenPatient Acquisition
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Clinical trial of novel innate immune system checkpoint inhibitor targeting myeloid derived suppressor cell ...
SANTA MONICA, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email